LS Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9,852
Closed -$885K 320
2021
Q1
$885K Sell
9,852
-1,428
-13% -$134K 0.05% 247
2020
Q4
$1.04M Buy
11,280
+2,060
+22% +$184K 0.06% 270
2020
Q3
$950K Buy
9,220
+24
+0.3% +$2.51K 0.05% 263
2020
Q2
$932K Buy
9,196
+8,896
+2,965% +$796K 0.06% 264
2020
Q1
$20K Sell
300
-2,060
-87% -$128K ﹤0.01% 1359
2019
Q4
$129K Hold
2,360
0.01% 1013
2019
Q3
$88K Buy
2,360
+120
+5% +$4.66K 0.01% 1115
2019
Q2
$84K Hold
2,240
0.01% 1143
2019
Q1
$67K Hold
2,240
﹤0.01% 1218
2018
Q4
$67K Buy
+2,240
New +$71.1K ﹤0.01% 1182
2017
Q4
Sell
-5,476
Closed -$67K 1880
2017
Q3
$67K Hold
5,476
﹤0.01% 1264
2017
Q2
$100K Hold
5,476
0.01% 1135
2017
Q1
$116K Hold
5,476
0.01% 1075
2016
Q4
$82K Buy
+5,476
New +$97K 0.01% 1108

Other funds holding DXCM

LS Investment Advisors's DXCM Position: Q2 2021 in Review

LS Investment Advisors sold out of DexCom (DXCM) in Q2 2021, closing a stake of 9,852 shares — an estimated $885K sold.

LS Investment Advisors first reported a position in DXCM in Q4 2016 and held it in 14 quarters. The position peaked at $1.04M in Q4 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • LS Investment Advisors reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 9,852 DexCom shares in Q2 2021, an estimated $885K.
  • LS Investment Advisors first reported a position in DexCom in Q4 2016 and held it in 14 quarters.
  • LS Investment Advisors's DexCom position peaked at $1.04M in Q4 2020.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.